Global Flexible Biomanufacturing Platform Market
Global Flexible Biomanufacturing Platform Market

Flexible Biomanufacturing Platform Comprehensive Study by Type (Single-use Technology, Modular Environment, Advanced Process Automation, Standardization), Modality (Machine Flexibility, Material Handling Flexibility, Operational Flexibility) Players and Region - Global Market Outlook to 2026

Flexible Biomanufacturing Platform Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jun 2021 Edition 224 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Flexible Biomanufacturing Platform Market Overview:
The flexible biomanufacturing platform is defined by operational and functional integration in the biomanufacturing process in order to react swiftly to changing markets and production capacity demands for quality, cost, complexity, and scale improvements. Various flexible models for biomanufacturing plants have been presented, which can be adjusted according to program needs. The flexible biomanufacturing platform incorporates a number of tools in the process, including the ability to manufacture multiple products with the quick changeover, simple manufacturing process adoption, support for both large and small volume production requirements, and easy conversion from clinical to commercial production. Equipment, processes, and manufacturing can all be made more flexible.

Growth Drivers
  • New Product Development toward more Personalized Products
  • Increasing Pressure to Reduce Manufacturing Costs

Roadblocks
  • High Initial Set-up Cost

Opportunities
  • Globalization of the Biopharmaceutical Industry
  • Rising Number of Complex Molecules in the Biologic Pipeline

Challenges
  • Regulatory Requirements
  • Requirement of Substantial Pre-planning


Competitive Landscape:
The companies are exploring the market by adopting expansions, investments, and new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.
Some of the key players profiled in the report are GE Healthcare Life Sciences (United States), Patheon, Inc. (United States), JHL Biotech (China), Xcellerex, Inc. (United States), McKinsey & Company (United States), Nelson Biomedical (Nigeria), Setpoint Systems, Inc. (United States), R-Pharm (Russia) and Blue Ocean Biomanufacturing (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Flexible Biomanufacturing Platform market by 2026. Considering Market by Modality, the sub-segment i.e. Machine Flexibility will boost the Flexible Biomanufacturing Platform market.

What Can be Explored with the Flexible Biomanufacturing Platform Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Flexible Biomanufacturing Platform Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Flexible Biomanufacturing Platform
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Flexible Biomanufacturing Platform market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Flexible Biomanufacturing Platform market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Flexible Biomanufacturing Platform Provider, Government Regulatory and Research Organizations and End-Use Industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global Flexible Biomanufacturing Platform Market?
The Flexible Biomanufacturing Platform market is expected to see a CAGR of % during projected year 2020 to 2026.

2. Who are the top performing companies in Flexible Biomanufacturing Platform Market?
Top performing companies in the Global Flexible Biomanufacturing Platform market are GE Healthcare Life Sciences (United States), Patheon, Inc. (United States), JHL Biotech (China), Xcellerex, Inc. (United States), McKinsey & Company (United States), Nelson Biomedical (Nigeria), Setpoint Systems, Inc. (United States), R-Pharm (Russia) and Blue Ocean Biomanufacturing (United States), to name a few.

3. What trending factors would impact Flexible Biomanufacturing Platform Market growth most?
"Advancements in Bioprocesses and Capabilities " is seen as one of major influencing trends for Flexible Biomanufacturing Platform Market during projected period 2020-2026.

Report Objectives / Segmentation Covered
By Type
  • Single-use Technology
  • Modular Environment
  • Advanced Process Automation
  • Standardization
By Modality
  • Machine Flexibility
  • Material Handling Flexibility
  • Operational Flexibility

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. New Product Development toward more Personalized Products
      • 3.2.2. Increasing Pressure to Reduce Manufacturing Costs
    • 3.3. Market Challenges
      • 3.3.1. Regulatory Requirements
      • 3.3.2. Requirement of Substantial Pre-planning
    • 3.4. Market Trends
      • 3.4.1. Advancements in Bioprocesses and Capabilities
      • 3.4.2. Rapid Increase in Product Approvals in the Pharmaceutical Sector
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Flexible Biomanufacturing Platform, by Type, Modality and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Flexible Biomanufacturing Platform (Value)
      • 5.2.1. Global Flexible Biomanufacturing Platform by: Type (Value)
        • 5.2.1.1. Single-use Technology
        • 5.2.1.2. Modular Environment
        • 5.2.1.3. Advanced Process Automation
        • 5.2.1.4. Standardization
      • 5.2.2. Global Flexible Biomanufacturing Platform by: Modality (Value)
        • 5.2.2.1. Machine Flexibility
        • 5.2.2.2. Material Handling Flexibility
        • 5.2.2.3. Operational Flexibility
      • 5.2.3. Global Flexible Biomanufacturing Platform Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Flexible Biomanufacturing Platform: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GE Healthcare Life Sciences (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Patheon, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. JHL Biotech (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Xcellerex, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. McKinsey & Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Nelson Biomedical (Nigeria)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Setpoint Systems, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. R-Pharm (Russia)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Blue Ocean Biomanufacturing (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Flexible Biomanufacturing Platform Sale, by Type, Modality and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Flexible Biomanufacturing Platform (Value)
      • 7.2.1. Global Flexible Biomanufacturing Platform by: Type (Value)
        • 7.2.1.1. Single-use Technology
        • 7.2.1.2. Modular Environment
        • 7.2.1.3. Advanced Process Automation
        • 7.2.1.4. Standardization
      • 7.2.2. Global Flexible Biomanufacturing Platform by: Modality (Value)
        • 7.2.2.1. Machine Flexibility
        • 7.2.2.2. Material Handling Flexibility
        • 7.2.2.3. Operational Flexibility
      • 7.2.3. Global Flexible Biomanufacturing Platform Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Flexible Biomanufacturing Platform: by Type(USD Million)
  • Table 2. Flexible Biomanufacturing Platform Single-use Technology , by Region USD Million (2015-2020)
  • Table 3. Flexible Biomanufacturing Platform Modular Environment , by Region USD Million (2015-2020)
  • Table 4. Flexible Biomanufacturing Platform Advanced Process Automation , by Region USD Million (2015-2020)
  • Table 5. Flexible Biomanufacturing Platform Standardization , by Region USD Million (2015-2020)
  • Table 6. Flexible Biomanufacturing Platform: by Modality(USD Million)
  • Table 7. Flexible Biomanufacturing Platform Machine Flexibility , by Region USD Million (2015-2020)
  • Table 8. Flexible Biomanufacturing Platform Material Handling Flexibility , by Region USD Million (2015-2020)
  • Table 9. Flexible Biomanufacturing Platform Operational Flexibility , by Region USD Million (2015-2020)
  • Table 10. South America Flexible Biomanufacturing Platform, by Country USD Million (2015-2020)
  • Table 11. South America Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 12. South America Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 13. Brazil Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 14. Brazil Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 15. Argentina Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 16. Argentina Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 17. Rest of South America Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 18. Rest of South America Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 19. Asia Pacific Flexible Biomanufacturing Platform, by Country USD Million (2015-2020)
  • Table 20. Asia Pacific Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 21. Asia Pacific Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 22. China Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 23. China Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 24. Japan Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 25. Japan Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 26. India Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 27. India Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 28. South Korea Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 29. South Korea Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 30. Taiwan Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 31. Taiwan Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 32. Australia Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 33. Australia Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 35. Rest of Asia-Pacific Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 36. Europe Flexible Biomanufacturing Platform, by Country USD Million (2015-2020)
  • Table 37. Europe Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 38. Europe Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 39. Germany Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 40. Germany Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 41. France Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 42. France Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 43. Italy Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 44. Italy Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 45. United Kingdom Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 46. United Kingdom Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 47. Netherlands Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 48. Netherlands Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 49. Rest of Europe Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 50. Rest of Europe Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 51. MEA Flexible Biomanufacturing Platform, by Country USD Million (2015-2020)
  • Table 52. MEA Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 53. MEA Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 54. Middle East Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 55. Middle East Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 56. Africa Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 57. Africa Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 58. North America Flexible Biomanufacturing Platform, by Country USD Million (2015-2020)
  • Table 59. North America Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 60. North America Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 61. United States Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 62. United States Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 63. Canada Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 64. Canada Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 65. Mexico Flexible Biomanufacturing Platform, by Type USD Million (2015-2020)
  • Table 66. Mexico Flexible Biomanufacturing Platform, by Modality USD Million (2015-2020)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Flexible Biomanufacturing Platform: by Type(USD Million)
  • Table 77. Flexible Biomanufacturing Platform Single-use Technology , by Region USD Million (2021-2026)
  • Table 78. Flexible Biomanufacturing Platform Modular Environment , by Region USD Million (2021-2026)
  • Table 79. Flexible Biomanufacturing Platform Advanced Process Automation , by Region USD Million (2021-2026)
  • Table 80. Flexible Biomanufacturing Platform Standardization , by Region USD Million (2021-2026)
  • Table 81. Flexible Biomanufacturing Platform: by Modality(USD Million)
  • Table 82. Flexible Biomanufacturing Platform Machine Flexibility , by Region USD Million (2021-2026)
  • Table 83. Flexible Biomanufacturing Platform Material Handling Flexibility , by Region USD Million (2021-2026)
  • Table 84. Flexible Biomanufacturing Platform Operational Flexibility , by Region USD Million (2021-2026)
  • Table 85. South America Flexible Biomanufacturing Platform, by Country USD Million (2021-2026)
  • Table 86. South America Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 87. South America Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 88. Brazil Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 89. Brazil Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 90. Argentina Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 91. Argentina Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 92. Rest of South America Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 93. Rest of South America Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 94. Asia Pacific Flexible Biomanufacturing Platform, by Country USD Million (2021-2026)
  • Table 95. Asia Pacific Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 96. Asia Pacific Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 97. China Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 98. China Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 99. Japan Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 100. Japan Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 101. India Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 102. India Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 103. South Korea Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 104. South Korea Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 105. Taiwan Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 106. Taiwan Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 107. Australia Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 108. Australia Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 109. Rest of Asia-Pacific Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 110. Rest of Asia-Pacific Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 111. Europe Flexible Biomanufacturing Platform, by Country USD Million (2021-2026)
  • Table 112. Europe Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 113. Europe Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 114. Germany Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 115. Germany Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 116. France Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 117. France Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 118. Italy Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 119. Italy Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 120. United Kingdom Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 121. United Kingdom Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 122. Netherlands Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 123. Netherlands Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 124. Rest of Europe Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 125. Rest of Europe Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 126. MEA Flexible Biomanufacturing Platform, by Country USD Million (2021-2026)
  • Table 127. MEA Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 128. MEA Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 129. Middle East Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 130. Middle East Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 131. Africa Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 132. Africa Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 133. North America Flexible Biomanufacturing Platform, by Country USD Million (2021-2026)
  • Table 134. North America Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 135. North America Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 136. United States Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 137. United States Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 138. Canada Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 139. Canada Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 140. Mexico Flexible Biomanufacturing Platform, by Type USD Million (2021-2026)
  • Table 141. Mexico Flexible Biomanufacturing Platform, by Modality USD Million (2021-2026)
  • Table 142. Research Programs/Design for This Report
  • Table 143. Key Data Information from Secondary Sources
  • Table 144. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Flexible Biomanufacturing Platform: by Type USD Million (2015-2020)
  • Figure 5. Global Flexible Biomanufacturing Platform: by Modality USD Million (2015-2020)
  • Figure 6. South America Flexible Biomanufacturing Platform Share (%), by Country
  • Figure 7. Asia Pacific Flexible Biomanufacturing Platform Share (%), by Country
  • Figure 8. Europe Flexible Biomanufacturing Platform Share (%), by Country
  • Figure 9. MEA Flexible Biomanufacturing Platform Share (%), by Country
  • Figure 10. North America Flexible Biomanufacturing Platform Share (%), by Country
  • Figure 11. Global Flexible Biomanufacturing Platform share by Players 2020 (%)
  • Figure 12. Global Flexible Biomanufacturing Platform share by Players (Top 3) 2020(%)
  • Figure 13. Global Flexible Biomanufacturing Platform share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. GE Healthcare Life Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 16. GE Healthcare Life Sciences (United States) Revenue: by Geography 2020
  • Figure 17. Patheon, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Patheon, Inc. (United States) Revenue: by Geography 2020
  • Figure 19. JHL Biotech (China) Revenue, Net Income and Gross profit
  • Figure 20. JHL Biotech (China) Revenue: by Geography 2020
  • Figure 21. Xcellerex, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Xcellerex, Inc. (United States) Revenue: by Geography 2020
  • Figure 23. McKinsey & Company (United States) Revenue, Net Income and Gross profit
  • Figure 24. McKinsey & Company (United States) Revenue: by Geography 2020
  • Figure 25. Nelson Biomedical (Nigeria) Revenue, Net Income and Gross profit
  • Figure 26. Nelson Biomedical (Nigeria) Revenue: by Geography 2020
  • Figure 27. Setpoint Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Setpoint Systems, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. R-Pharm (Russia) Revenue, Net Income and Gross profit
  • Figure 30. R-Pharm (Russia) Revenue: by Geography 2020
  • Figure 31. Blue Ocean Biomanufacturing (United States) Revenue, Net Income and Gross profit
  • Figure 32. Blue Ocean Biomanufacturing (United States) Revenue: by Geography 2020
  • Figure 33. Global Flexible Biomanufacturing Platform: by Type USD Million (2021-2026)
  • Figure 34. Global Flexible Biomanufacturing Platform: by Modality USD Million (2021-2026)
  • Figure 35. South America Flexible Biomanufacturing Platform Share (%), by Country
  • Figure 36. Asia Pacific Flexible Biomanufacturing Platform Share (%), by Country
  • Figure 37. Europe Flexible Biomanufacturing Platform Share (%), by Country
  • Figure 38. MEA Flexible Biomanufacturing Platform Share (%), by Country
  • Figure 39. North America Flexible Biomanufacturing Platform Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • GE Healthcare Life Sciences (United States)
  • Patheon, Inc. (United States)
  • JHL Biotech (China)
  • Xcellerex, Inc. (United States)
  • McKinsey & Company (United States)
  • Nelson Biomedical (Nigeria)
  • Setpoint Systems, Inc. (United States)
  • R-Pharm (Russia)
  • Blue Ocean Biomanufacturing (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation